Eomesodermin promotes interaction of RelA and NFATc2 with the Ifng promoter and multiple conserved noncoding sequences across the Ifng locus in mouse lymphoma BW5147 cells

Immunol Lett. 2020 Sep:225:33-43. doi: 10.1016/j.imlet.2020.06.008. Epub 2020 Jun 15.

Abstract

The T-box transcription factor Eomesodermin (Eomes) regulates the lineage-dependent expression of interferon γ (IFN-γ). We previously showed that Eomes promotes IFN-γ production and interacts with multiple conserved noncoding sequences (CNS) across the Ifng locus in mouse lymphoma BW5147 cells. In the present study, we investigated the transcriptional regulation of IFN-γ by the nuclear factor κB (NF-κB) subunit RelA and nuclear factor of activated T cells c2 (NFATc2, also known as NFAT1) in Eomes-transfected BW5147 cells. Eomes promoted the interaction of RelA and NFATc2 with the Ifng promoter and five CNS, including CNS-22 and CNS+30 upon stimulation with phorbol 12-myristate 13-acetate (PMA) and ionomycin (IM). The dual NF-κB and STAT3 inhibitor TPCA-1 moderately reduced the PMA- and IM-induced IFN-γ transcription in Eomes-transfected BW5147 cells. TPCA-1 interfered with RelA binding to the Ifng promoter, CNS-22 and CNS+30. Moreover, TPCA-1 reduced the interaction of Eomes or NFATc2 with the Ifng promoter and CNS+30. The present results indicate that Eomes promotes the interaction of RelA and NFATc2 with the Ifng promoter and multiple CNS across the Ifng locus in BW5147 cells.

Keywords: Eomesodermin; IFN-γ; NF-κB; NFAT; TPCA-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / therapeutic use*
  • Animals
  • Cell Line, Tumor
  • Conserved Sequence / genetics
  • Gene Expression Regulation, Neoplastic
  • Genetic Loci / genetics
  • Interferon-gamma / genetics
  • Lymphoma / drug therapy
  • Lymphoma / genetics*
  • Mice
  • NFATC Transcription Factors / metabolism*
  • Promoter Regions, Genetic / genetics
  • Protein Kinase Inhibitors / pharmacology
  • STAT3 Transcription Factor / antagonists & inhibitors
  • T-Box Domain Proteins / metabolism*
  • Thiophenes / therapeutic use*
  • Transcription Factor RelA / metabolism*

Substances

  • Amides
  • Eomes protein, mouse
  • NFATC Transcription Factors
  • Protein Kinase Inhibitors
  • Rela protein, mouse
  • STAT3 Transcription Factor
  • T-Box Domain Proteins
  • Thiophenes
  • Transcription Factor RelA
  • Interferon-gamma
  • 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide